The model predicts quite substantial increases in both HBV and HCV prevalence rates for both males and females, particularly for HCV, which could outpace HBV infection for both genders.
|
| Figure 3: The predicted estimates of HBV and HCV prevalence for 2011-2013
based on 2008-2010 analysis by using the logistic regression model. The model predicts quite substantial increases in both HBV and HCV prevalence rates for both males and females, particularly for HCV, which could outpace HBV infection for both genders. |
